Aberdeen Group’s Medical Properties Trust MPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$975K Buy
211,059
+20,600
+11% +$102K ﹤0.01% 834
2026
Q1
$882K Sell
190,459
-273,837
-59% -$1.43M ﹤0.01% 836
2025
Q4
$2.32M Buy
464,296
+2,145
+0.5% +$11.2K ﹤0.01% 765
2025
Q3
$2.29M Sell
462,151
-123,177
-21% -$543K ﹤0.01% 767
2025
Q2
$2.52M Sell
585,328
-8,194
-1% -$40.5K ﹤0.01% 763
2025
Q1
$3.58M Buy
593,522
+5,521
+0.9% +$27.9K 0.01% 711
2024
Q4
$2.19M Buy
588,001
+56,392
+11% +$253K ﹤0.01% 756
2024
Q3
$3.11M Buy
531,609
+11,504
+2% +$56.7K 0.01% 725
2024
Q2
$2.24M Buy
520,105
+1,887
+0.4% +$9.04K ﹤0.01% 741
2024
Q1
$2.44M Sell
518,218
-8,920
-2% -$34.2K ﹤0.01% 754
2023
Q4
$2.59M Buy
527,138
+401,920
+321% +$1.97M 0.01% 755
2023
Q3
$682K Buy
125,218
+2,622
+2% +$21K ﹤0.01% 787
2023
Q2
$1.14M Sell
122,596
-11,214
-8% -$94.8K ﹤0.01% 779
2023
Q1
$1.1M Buy
133,810
+5,987
+5% +$66.1K ﹤0.01% 787
2022
Q4
$1.42M Sell
127,823
-14,072
-10% -$164K ﹤0.01% 737
2022
Q3
$1.68M Sell
141,895
-99,778
-41% -$1.51M 0.01% 732
2022
Q2
$3.85M Sell
241,673
-143,113
-37% -$2.57M 0.01% 605
2022
Q1
$8.22M Buy
384,786
+448
+0.1% +$9.65K 0.02% 484
2021
Q4
$9.08M Buy
384,338
+7,744
+2% +$166K 0.02% 509
2021
Q3
$7.79M Buy
376,594
+1,021
+0.3% +$20.9K 0.02% 564
2021
Q2
$7.55M Buy
375,573
+54,651
+17% +$1.17M 0.02% 563
2021
Q1
$6.83M Sell
320,922
-582,132
-64% -$12.5M 0.02% 574
2020
Q4
$19.7M Buy
903,054
+9,707
+1% +$189K 0.05% 322
2020
Q3
$15.8M Sell
893,347
-24,647
-3% -$459K 0.04% 334
2020
Q2
$17.3M Buy
917,994
+8,297
+0.9% +$147K 0.05% 321
2020
Q1
$15.7M Buy
909,697
+121,986
+15% +$2.55M 0.05% 313
2019
Q4
$16.6M Buy
787,711
+701,217
+811% +$14.2M 0.04% 363
2019
Q3
$1.69M Buy
86,494
+4,062
+5% +$74.6K ﹤0.01% 735
2019
Q2
$1.44M Hold
82,432
﹤0.01% 785
2019
Q1
$1.53M Sell
82,432
-13,710
-14% -$244K ﹤0.01% 762
2018
Q4
$1.55M Hold
96,142
﹤0.01% 721
2018
Q3
$1.43M Buy
+96,142
New +$1.4M ﹤0.01% 763

Other funds holding MPT

Aberdeen Group's MPT Position: Q2 2026 in Review

Aberdeen Group increased its Medical Properties Trust (MPT) stake by 11% in Q2 2026, buying an estimated $102K and bringing the position to 211,059 shares worth $975K. The position accounts for ﹤0.01% of the portfolio, ranked #834.

Aberdeen Group first reported a position in MPT in Q3 2018 and has held it in 32 quarters since. The position peaked at $19.7M in Q4 2020. 158 funds tracked by Wall St. Rank hold MPT as of Q2 2026.

  • Aberdeen Group held 211,059 shares of Medical Properties Trust worth $975K as of Q2 2026.
  • Aberdeen Group bought 20,600 Medical Properties Trust shares in Q2 2026, an estimated $102K.
  • Medical Properties Trust made up ﹤0.01% of Aberdeen Group's portfolio in Q2 2026, its #834 holding.
  • Aberdeen Group first reported a position in Medical Properties Trust in Q3 2018 and has held it in 32 quarters since.
  • Aberdeen Group's Medical Properties Trust position peaked at $19.7M in Q4 2020.
  • 158 funds tracked by Wall St. Rank held Medical Properties Trust as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.